You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the SODIUM ACETATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

SODIUM ACETATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Acetate patents expire, and what generic alternatives are available?

Sodium Acetate is a drug marketed by Fresenius Kabi Usa, Hikma, Hospira, and Milla Pharms. and is included in four NDAs.

The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Acetate

A generic version of SODIUM ACETATE was approved as sodium acetate by HOSPIRA on May 4th, 1983.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM ACETATE?
  • What are the global sales for SODIUM ACETATE?
  • What is Average Wholesale Price for SODIUM ACETATE?
Summary for SODIUM ACETATE
Drug patent expirations by year for SODIUM ACETATE
Drug Prices for SODIUM ACETATE

See drug prices for SODIUM ACETATE

US Patents and Regulatory Information for SODIUM ACETATE

SODIUM ACETATE is protected by zero US patents and one FDA Regulatory Exclusivity.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 206687-001 Oct 30, 2017 AP RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 018893-003 Sep 2, 2014 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 216920-003 Mar 15, 2024 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Milla Pharms SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 214805-004 Jan 22, 2024 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 216920-001 Mar 15, 2024 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hikma SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 216920-002 Mar 15, 2024 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira SODIUM ACETATE sodium acetate SOLUTION;INTRAVENOUS 018893-002 Sep 2, 2014 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SODIUM ACETATE Market Analysis and Financial Projection Experimental

Sodium Acetate Market Dynamics and Financial Trajectory

Market Overview

The sodium acetate market is poised for significant growth, driven by its versatile applications across various industries. The market size is estimated to reach $380 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period of 2024-2030[1][3][4].

Key Drivers of Growth

Several factors are driving the growth of the sodium acetate market:

Pharmaceutical Industry

The pharmaceutical sector has been a major driver, particularly with the surge in demand post-COVID-19. Sodium acetate plays a crucial role as a pH regulator and buffering agent in pharmaceutical formulations, ensuring the stability and efficacy of medications. India's pharmaceutical exports, for instance, stood at $25.3 billion in FY23, and the domestic market is projected to reach $130 billion by 2030[1][3].

Food and Beverage Industry

In the food sector, sodium acetate is used as a preservative, flavor enhancer, microbial inhibitor, and emulsifier. The growing demand for canned foods, especially in Asia-Pacific countries like China, India, and Vietnam, has significantly contributed to the market's growth. For example, Vietnam's canned tuna exports exceeded $135 million by July 2023[1][3].

Building and Construction Industry

The building and construction sector also drives demand for sodium acetate, particularly for its use in concrete sealants and de-icing agents. The rapid growth of this sector in Asia-Pacific countries is a key factor in the market's expansion[1][3].

Wastewater Treatment

The increasing need for wastewater treatment facilities is another significant driver. Sodium acetate is used in various wastewater treatment processes, contributing to the market's growth[3].

Geographical Analysis

The Asia-Pacific region dominates the sodium acetate market, holding a 45% market share in 2023. Countries such as China, India, Australia, and Japan are driving this growth due to their rapidly expanding food and beverage, and building and construction sectors[1][3].

Market Segmentation

The sodium acetate market is segmented by grade, packaging, application, and end-use industry.

By Grade

The market includes technical grade and industrial grade sodium acetate. Each grade has specific applications, with the technical grade often used in pharmaceuticals and the industrial grade in construction and other industrial processes[3].

By Packaging

Sodium acetate is available in various packaging forms such as packets, bags, and drums, catering to different industry needs[3].

By Application

Applications include concrete sealants, dye intermediates, disinfectants, buffering agents, additives, cleaning agents, and others. The versatility of sodium acetate in these applications contributes to its widespread use[3].

By End Use Industry

The key end-use industries are food and beverage, building and construction, wastewater treatment, textiles, cosmetics and personal care, and pharmaceuticals. Each industry has unique requirements that sodium acetate fulfills effectively[1][3].

Financial Trajectory

The financial outlook for the sodium acetate market is promising:

Market Size

The global sodium acetate market size was valued at $246 million in 2023 and is projected to reach $380 million by 2030[1][3].

CAGR

The market is growing at a CAGR of 7.5% during the forecast period of 2024-2030[1][3][4].

Regional Growth

North America is expected to grow at the fastest pace during the forecast period, driven by increased healthcare spending and rising consumer awareness, particularly in medical and pharmaceutical applications[4].

Key Players and Competitive Landscape

The market is competitive, with key players such as Merck KGaA, FoodChem International Corporation, Kerry Group plc, Cayman Chemical, and Mitsubishi Chemical Corporation. These companies are involved in various strategies including product development, innovations, joint ventures, and strategic alliances to maintain their market share[1][4].

Challenges and Opportunities

While the market faces challenges such as fluctuations in raw material prices and regulatory hurdles, there are significant opportunities for growth:

Raw Material Fluctuations

The price trend of sodium acetate can be uncertain due to pressures on the raw materials sector, such as rising rates and supply chain disruptions[5].

Regulatory Approvals

Setting up a sodium acetate manufacturing plant requires detailed regulatory approvals and compliance with various certifications, which can be a challenge but also presents an opportunity for companies that can navigate these requirements effectively[2].

Setting Up a Manufacturing Plant

For companies looking to enter the market, setting up a manufacturing plant involves detailed project economics, including capital investments, operating expenses, and financial analysis. The report by IMARC Group provides a comprehensive roadmap for setting up a sodium acetate manufacturing plant, covering aspects such as raw material requirements, machinery, and regulatory procedures[2].

Key Takeaways

  • Growing Demand: The sodium acetate market is driven by growing demand from the pharmaceutical, food and beverage, and building and construction industries.
  • Geographical Dominance: The Asia-Pacific region dominates the market, with a 45% share in 2023.
  • Financial Growth: The market is expected to reach $380 million by 2030, growing at a CAGR of 7.5%.
  • Versatile Applications: Sodium acetate is used in various applications, including pH regulation, preservatives, and de-icing agents.
  • Competitive Landscape: Key players are engaging in various strategies to maintain market share.

FAQs

Q: What is the projected market size of the sodium acetate market by 2030? A: The sodium acetate market is estimated to reach $380 million by 2030[1][3].

Q: What is the CAGR of the sodium acetate market during the forecast period? A: The market is growing at a CAGR of 7.5% during the forecast period of 2024-2030[1][3][4].

Q: Which region dominates the sodium acetate market? A: The Asia-Pacific region dominates the market, holding a 45% market share in 2023[1][3].

Q: What are the primary applications of sodium acetate? A: Sodium acetate is used as a pH regulator, preservative, flavor enhancer, microbial inhibitor, and in various other applications across different industries[1][3].

Q: Who are the key players in the sodium acetate market? A: Key players include Merck KGaA, FoodChem International Corporation, Kerry Group plc, Cayman Chemical, and Mitsubishi Chemical Corporation[1][4].

Citations

  1. IndustryARC, "Sodium Acetate Market Size, Share, Industry Trend & Forecast 2030"
  2. IMARC Group, "Sodium Acetate Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue"
  3. IndustryARC, "Sodium Acetate Market - Forecast, 2024-2030"
  4. Spherical Insights, "Global Sodium Acetate Market Size, Share, Forecasts to 2033"
  5. Procurement Resource, "Sodium Acetate Price Trend, Index, News, Chart, Database"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.